Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A

Acquired haemophilia A (AHA) is a rare haemorrhagic disorder caused by the development of autoantibodies inhibiting factor VIII function. It predominantly affects the elderly, who are often burdened with a considerable number of comorbidities, and can result in life-threatening bleeding. The managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Banaa, Kadhim, Gallastegui-Crestani, Nicolas, von Drygalski, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667998/
https://www.ncbi.nlm.nih.gov/pubmed/34912741
http://dx.doi.org/10.12890/2021_002984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667998/
https://www.ncbi.nlm.nih.gov/pubmed/34912741
http://dx.doi.org/10.12890/2021_002984

Ejemplares similares